Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04763915 · ClinicalTrials.gov registry record · NA

Improving Care After Inherited Cancer Testing

A NA study of Breast Cancer and Prostate Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

Active
Registry status
NA
Development phase
720
Enrollment target
1
Study location

NCT04763915: Active NA study of Breast Cancer and Prostate Cancer, sponsored by Vanderbilt-Ingram Cancer Center.

NCT04763915 is a NA study of Breast Cancer and Prostate Cancer that is active but no longer recruiting, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 720 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04763915, a NA study of Breast Cancer and Prostate Cancer, is active but no longer recruiting, sponsored by Vanderbilt-Ingram Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
720 participants
Enrollment target
1
Study location

Study Summary

The IMPACT Study seeks to refine and evaluate the effectiveness of interventions on improving guideline-adherent cancer risk management (CRM) and family communication (FC) of genetic test results for individuals with a documented pathogenic/likely pathogenic (P/LP) variant, and FC of family cancer history for individuals with a variant of uncertain significance (VUS) in an inherited cancer gene.

Primary Outcome

Having at least one additional at-risk adult, living relative with whom the participant has shared their test result, information about testing, or family history of cancer for the first time or has subsequently followed up with a relative

Interventions

  • OTHER Correlative Studies (Survey)
  • OTHER Correlative Studies (Interview)
  • BEHAVIORAL GeneSHARE
  • BEHAVIORAL LivingLabReport
  • BEHAVIORAL Standard-of-care & Adaptive Intervention

Study Locations (1)

Tennessee

  • Vanderbilt-Ingram Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 720 participants
Start Date 2022-08-05
Est. Completion 2028-12
Phase NA
Vanderbilt-Ingram Cancer Center

189 total trials

What the registry record for NCT04763915 still lists

NCT04763915 is an interventional study that assigns participants to a tested intervention. The registered 720 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (74% lower).

The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which Correlative Studies (Survey) is the first listed.

NCT04763915 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT04763915 about?

NCT04763915 is a clinical study titled "Improving Care After Inherited Cancer Testing". The IMPACT Study seeks to refine and evaluate the effectiveness of interventions on improving guideline-adherent cancer risk management (CRM) and family communication (FC) of genetic test results for individuals with a documented pathogenic/likely pathogenic (P/LP) variant, and FC of family cancer h...

What is the current status of trial NCT04763915?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 720 participants. The study started on 2022-08-05. Estimated completion is 2028-12.

What conditions does trial NCT04763915 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Colorectal Cancer, Endometrial Cancer, Inherited Cancer Syndrome.

What interventions are being tested in trial NCT04763915?

The interventions under investigation include: Correlative Studies (Survey) (OTHER), Correlative Studies (Interview) (OTHER), GeneSHARE (BEHAVIORAL), LivingLabReport (BEHAVIORAL), Standard-of-care & Adaptive Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04763915?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04763915 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04763915's enrollment target sits among peer trials

720 157th of 1224 higher than 1,067 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

  • NCT05047224 · 720 participants · NA

    Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

  • NCT05309395 · 720 participants · Phase 3

    Food Prescriptions to Promote Affordable Diets

  • NCT05466214 · 720 participants · NA

    Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Elementary Schools

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04763915, the US trial registry maintained by the National Library of Medicine. NCT04763915 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.